<DOC>
	<DOCNO>NCT02848768</DOCNO>
	<brief_summary>The purpose study validate predictive nomogram response resistance target therapy metastatic clear cell renal cell carcinoma</brief_summary>
	<brief_title>Validation Predictive Nomogram Response Resistance Targeted Therapies Metastatic Clear Cell Renal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>patient metastatic ccRCC Underwent nephrectomy University Hospital Rennes treat sunitinib first line treatment translocation renal cell carcinoma target therapy sunitinib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>